Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug discovery for inflammatory diseases.

Inez Rogatsky1

  • 1Department of Cellular and Molecular Pharmacology, University of California, San Francisco, Genentech Hall, Rm. S574, 600 16th Street, San Francisco, California 94143-2280, USA. inez2@itsa.ucsf.edu

Expert Opinion on Biological Therapy
|August 29, 2003
PubMed
Summary

This conference explored novel drug discovery strategies for inflammatory diseases, focusing on immune system modulation for autoimmune conditions, vaccines, and cancer therapy. Key research areas included cytokine roles, Toll-like receptor targeting, and glucocorticoid mechanisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interleukin-12 induces rapid STAT4/DDX5-dependent remodeling of RNA polymerase II occupancy in NK cells.

The Journal of experimental medicine·2026
Same author

Selective Glucocorticoid Receptor Modulators of Immune Checkpoint Function.

bioRxiv : the preprint server for biology·2026
Same author

Disrupting the RNA polymerase II transcription cycle through CDK7 inhibition ameliorates inflammatory arthritis.

Science translational medicine·2024
Same author

Mechanisms of epigenomic and functional convergence between glucocorticoid- and IL4-driven macrophage programming.

Nature communications·2024
Same author

Fasting reshapes tissue-specific niches to improve NK cell-mediated anti-tumor immunity.

Immunity·2024
Same author

The interferon-rich skin environment regulates Langerhans cell ADAM17 to promote photosensitivity in lupus.

eLife·2024

Area of Science:

  • Immunology
  • Pharmacology
  • Biotechnology

Background:

  • Inflammatory diseases pose significant challenges in treatment and management.
  • Current drug discovery efforts aim to develop targeted therapies for autoimmune and inflammatory conditions.
  • Advances in understanding immune system components are crucial for novel therapeutic strategies.

Purpose of the Study:

  • To review key findings and emerging research from the Drug Discovery for Inflammatory Diseases conference.
  • To highlight advancements in targeting immune responses for therapeutic benefit.
  • To discuss novel approaches in drug design and clinical studies for inflammatory diseases.

Main Methods:

  • The review focuses on selected presentations from a 3-day conference.

Related Experiment Videos

  • Key research areas discussed include cytokine function, Toll-like receptor (TLR) targeting, and glucocorticoid mechanisms.
  • Discussions encompass basic science, drug design, and clinical applications.

    • Main Results:

    • Leptin's role in autoimmunity was examined.
    • Targeting Toll-like receptors for vaccine development and cancer therapy was a significant focus.
    • Molecular mechanisms of glucocorticoid-mediated repression and selective anti-inflammatory glucocorticoids were dissected.

    Conclusions:

    • The conference showcased diverse strategies for modulating immune responses in inflammatory diseases.
    • Targeting specific pathways like TLRs and understanding cytokine functions offer promising avenues for drug discovery.
    • Further research into glucocorticoid mechanisms could yield more selective anti-inflammatory agents.